Global Longlife Hospital & Research Stock Screener | Share Price & Fundamental Analysis
GLHRL
Hospitals
Track Global Longlife Hospital & Research share price live with TickJournal's free stock screener.
Browse Global Longlife Hospital & Res annual reports to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Global Longlife Hospital & Research Market Cap
₹15.81 Cr.
GLHRL P/E Ratio (TTM)
82.11
Global Longlife Hospital & Research P/B Ratio
0.61
EPS (TTM)
₹0.19
Dividend Yield
-
Debt to Equity
0.24
GLHRL 52 Week High
-
Global Longlife Hospital & Research 52 Week Low
-
Operating Margin
9.00%
Profit Margin
8.33%
GLHRL Revenue (TTM)
₹24.00
EBITDA
₹4.00
Net Income
₹2.00
Total Assets
₹27.00
Total Equity
₹27.00
Global Longlife Hospital & Research Share Price History - Stock Screener Chart
Screen GLHRL historical share price movements with interactive charts. Analyze price trends and patterns.
Global Longlife Hospital & Research Company Profile - Fundamental Screener
Screen Global Longlife Hospital & Research company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GLHRL shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE0J2K01014
Global Longlife Hospital & Research Balance Sheet Screener
Screen GLHRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 27 | 42 | 76 | 34 | 37 | 42 | 43 |
| Current Assets | 23 | 4 | 34 | 11 | 12 | 16 | 15 |
| Fixed Assets | 0 | 17 | 17 | 17 | 18 | 19 | 20 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 4 | 4 | 3 | 13 | 17 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 27 | 26 | 64 | 17 | 14 | 12 | 12 |
| Share Capital | 11 | 11 | 11 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 16 | 15 | 54 | 10 | 7 | 5 | 5 |
Global Longlife Hospital & Research Income Statement Screener - Profit & Revenue Analysis
Screen Global Longlife Hospital & Research income statement and profit fundamentals.
Analyze GLHRL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Global Longlife Hospital & Research share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 6 | 14 | 24 | 33 | 33 | 34 | 35 |
| Expenses | 19 | 5 | 14 | 20 | 25 | 27 | 30 | 28 |
| EBITDA | 4 | 1 | 0 | 4 | 8 | 6 | 4 | 7 |
| Operating Profit % | 9.00% | -720.00% | -2.00% | 17.00% | 24.00% | 17.00% | 10.00% | 20.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 |
| Profit Before Tax | 3 | 0 | -2 | 3 | 6 | 2 | -1 | 3 |
| Tax | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
| Net Profit | 2 | 0 | -2 | 2 | 4 | 2 | -1 | 1 |
| EPS | 1.80 | 0.19 | -2.08 | 1.79 | 5.11 | 2.92 | -1.23 | 1.95 |
Global Longlife Hospital & Research Cash Flow Screener - Liquidity Fundamentals
Screen GLHRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | -5 | -40 | 9 | 7 | 4 | 5 |
| Investing Activities | 22 | -1 | -2 | 0 | 0 | 0 | 0 |
| Financing Activities | -13 | 3 | 46 | -10 | -7 | -3 | -5 |
| Net Cash Flow | 21 | -3 | 3 | 0 | 0 | 1 | 0 |
Global Longlife Hospital & Research Shareholding Pattern Screener
See Global Longlife Hospital & Research shareholding pattern with promoter, FII, and DII holdings.
Check Global Longlife Hospital & Research promoter holding and ownership changes for GLHRL on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.44% | 55.10% | 54.90% | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 53.48% | 33.31% | 33.20% | 33.71% | 31.79% | 31.90% | 34.62% | 37.13% |
| Other Holding | 11.09% | 11.59% | 11.90% | 12.00% | 13.92% | 13.81% | 11.10% | 8.58% |
| Shareholder Count | 985 | 915 | 917 | 938 | 989 | 974 | 1,010 | 947 |
Global Longlife Hospital & Research Share Dividend Screener - Share Yield Analysis
Check Global Longlife Hospital & Research dividend history with payout and yield data.
View Global Longlife Hospital & Research dividend details including ex-dates and amounts for GLHRL stock.
Global Longlife Hospital & Research Stock Index Membership
See which indices include Global Longlife Hospital & Research stock.
Check GLHRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Global Longlife Hospital & Research Market Events Screener - Corporate Actions
Get Global Longlife Hospital & Research corporate actions including splits, bonuses, and buybacks.
Check Global Longlife Hospital & Research stock events that may affect GLHRL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -14.58% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 7.42% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | -8.48% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 4.65% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -9.89% |
| 2024-05-14 | 2024-05-14 | Extraordinary General Meeting | NA | -7.58% |
Global Longlife Hospital & Research Competitors Screener - Peer Comparison
Screen GLHRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 108,076 | 57.91 | 21,994 | 14.76% | 1,505 | 52.94 |
| Max Healthcare Institute | 92,613 | 65.43 | 7,184 | 28.68% | 1,076 | 39.45 |
| Fortis Healthcare | 64,190 | 65.24 | 7,850 | 13.25% | 809 | 52.08 |
| Narayana Hrudayalaya | 36,137 | 46.01 | 5,575 | 12.29% | 790 | 58.30 |
| Aster DM Healthcare | 34,509 | 98.30 | 4,287 | 15.12% | 337 | 53.24 |
| Global Health | 28,531 | 55.71 | 3,771 | 12.59% | 481 | 52.57 |
| Krishna Institute of Medical Sciences | 26,309 | 84.31 | 3,067 | 21.98% | 415 | 50.78 |
| Dr. Agarwal's Health Care | 13,724 | 85.85 | 1,757 | 27.64% | 110 | 51.10 |
| Rainbow Childrens Medicare | 12,957 | 48.85 | 1,567 | 17.46% | 244 | 66.17 |
| Kovai Medical Center Hospital | 12,305 | 25.00 | 600 | 11.69% | 58 | 57.32 |
Global Longlife Hospital & Research Company Announcements - News Screener
Screen GLHRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-31 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-03-31 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held Today I.E. Tuesday March 31 2026 | - |
| 2026-03-28 | Closure of Trading Window | - |
| 2026-01-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-01-21 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-29 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-26 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2025-11-12 | Unaudited Financial Results For The Half Year Ended September 30 2025 Along With Limited Review Report | - |
| 2025-11-12 | Board Meeting Outcome for Consideration And Approval Of Unaudited Financial Results For The Half Year Ended September 30 2025 Along With Limited Review Report And Other Matters | - |